Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When and where is factor XI activated by thrombin?

R W Colman, C F Scott

    Blood
    |March 1, 1996
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.

    Thrombosis and haemostasis·1999
    Same author

    Hypotensive reactions during transfusion: is bradykinin the culprit?

    Transfusion·1999
    Same author

    The two forms of karyogamy transcription factor Kar4p are regulated by differential initiation of transcription, translation, and protein turnover.

    Molecular and cellular biology·1998
    Same author

    Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters.

    Blood·1998
    Same author

    High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation.

    Blood·1997
    Same author

    Modulation of platelet responses by 2-[3-(bromo-2-oxopropylthio)]adenosine-5'-diphosphate involves its binding to as well as covalent modification of an ADP-receptor, aggregin.

    Archives of biochemistry and biophysics·1997
    Same journal

    Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.

    Blood·2026
    Same journal

    Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

    Blood·2026
    Same journal

    Single Cell Analysis of the Tumor Microenvironment Landscape Across the Disease Spectrum of Multiple Myeloma.

    Blood·2026
    Same journal

    Decentralized Clinical Trials in Hematology: the Promise and the Peril.

    Blood·2026
    Same journal

    How I Treat Chemotherapy-Induced Thrombocytopenia with Thrombopoietin Receptor Agonists.

    Blood·2026
    Same journal

    The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design.

    Blood·2026
    See all related articles